Browse by UCL Departments and Centres
![[up]](/style/images/multi_up.png)
Up a levelGroup by: Author | Type
Number of items: 101.
A
Abdollah, MRA;
(2016)
Developing superparamagnetic iron oxide nanoparticles as targeted cancer nanomedicine.
Doctoral thesis , UCL (University College London).
|
|
Alliouachene, S;
Bilanges, B;
Chaussade, C;
Pearce, W;
Foukas, LC;
Scudamore, CL;
Moniz, LS;
(2016)
Inactivation of class II PI3K-C2α induces leptin resistance, age-dependent insulin resistance and obesity in male mice.
Diabetologia
, 59
(7)
pp. 1503-1512.
10.1007/s00125-016-3963-y.
|
|
Ang, JE;
Pandher, R;
Ang, JC;
Asad, YJ;
Henley, A;
Valenti, M;
Box, G;
... Raynaud, FI; + view all
(2016)
Plasma metabolomic changes following PI3K inhibition as pharmacodynamic biomarkers: preclinical discovery to Phase I trial evaluation.
Molecular Cancer Therapeutics
, 15
(6)
pp. 1412-1424.
10.1158/1535-7163.MCT-15-0815.
|
|
Anjos-Afonso, F;
Loizou, JI;
Bradburn, A;
Kanu, N;
Purewal, S;
Da Costa, C;
Bonnet, D;
(2016)
Perturbed hematopoiesis in mice lacking ATMIN.
Blood
, 128
(16)
pp. 2017-2021.
10.1182/blood-2015-09-672980.
|
 |
|
Attard, G;
Antonarakis, ES;
(2016)
Prostate cancer: AR aberrations and resistance to abiraterone or enzalutamide.
Nature Reviews Urology
, 13
(12)
pp. 697-698.
10.1038/nrurol.2016.212.
|
|
B
|
Bendell, JC;
Patel, MR;
Yoshida, K;
Seraj, J;
Weaver, R;
Lemech, C;
Todaro, TG;
... Arkenau, H-T; + view all
(2016)
Phase 1 study of cardiac safety of TAS-102 in patients with advanced solid tumors.
Cancer Chemother Pharmacol
, 77
(6)
pp. 1275-1283.
10.1007/s00280-016-3031-9.
|
|
|
Bentham, RB;
(2016)
A bioinfomatic analysis of the role of mitochondrial biogenesis in human pathologies.
Doctoral thesis , UCL (University College London).
|
|
Bentzen, AK;
Marquard, AM;
Lyngaa, R;
Saini, SK;
Ramskov, S;
Donia, M;
Such, L;
... Hadrup, SR; + view all
(2016)
Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodes.
Nature Biotechnology
, 34
(10)
pp. 1037-1045.
10.1038/nbt.3662.
|
|
|
Braso-Maristany, F;
Filosto, S;
Catchpole, S;
Marlow, R;
Quist, J;
Francesch-Domenech, E;
Plumb, DA;
... Tutt, AN; + view all
(2016)
PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancer.
Nature Medicine
, 22
(11)
pp. 1303-1313.
10.1038/nm.4198.
|
|
C
|
Campbell, J;
Ryan, CJ;
Brough, R;
Bajrami, I;
Pemberton, HN;
Chong, IY;
Costa-Cabral, S;
... Lord, CJ; + view all
(2016)
Large-Scale Profiling of Kinase Dependencies in Cancer Cell Lines.
Cell Reports
, 14
(10)
pp. 2490-2501.
10.1016/j.celrep.2016.02.023.
|
|
Carter, T;
Mulholland, P;
Chester, K;
(2016)
Antibody-targeted nanoparticles for cancer treatment.
Immunotherapy
, 8
(8)
pp. 941-958.
10.2217/imt.16.11.
|
|
Carter, T;
Shawy, H;
Cohn-Brown, D;
Chester, K;
Mulholland, P;
(2016)
Ipilimumab and Bevacizumab in Glioblastoma.
Clinical Oncology
, 28
(10)
pp. 622-626.
10.1016/j.clon.2016.04.042.
|
|
|
Castillo, SD;
Tzouanacou, E;
Zaw-Thin, M;
Berenjeno, IM;
Parker, VE;
Chivite, I;
Milà-Guasch, M;
... Vanhaesebroeck, B; + view all
(2016)
Somatic activating mutations in Pik3ca cause sporadic venous malformations in mice and humans.
Science Translational Medicine
, 8
(332)
, Article 332ra43. 10.1126/scitranslmed.aad9982.
|
|
Castillo, SD;
Vanhaesebroeck, B;
Sebire, NJ;
(2016)
Phosphoinositide 3-kinase: a new kid on the block in vascular anomalies.
The Journal of Pathology
, 240
(4)
pp. 387-396.
10.1002/path.4802.
|
|
Chakravarthy, A;
Henderson, S;
Thirdborough, SM;
Ottensmeier, CH;
Su, X;
Lechner, M;
Feber, A;
... Fenton, TR; + view all
(2016)
Human Papillomavirus Drives Tumor Development Throughout the Head and Neck: Improved Prognosis Is Associated With an Immune Response Largely Restricted to the Oropharynx.
Journal Of Clinical Oncology
, 34
(34)
pp. 4132-4141.
10.1200/JCO.2016.68.2955.
|
|
|
Chatterjee, M;
Turner, DC;
Felip, E;
Lena, H;
Cappuzzo, F;
Horn, L;
Garon, EB;
... Flotten, O; + view all
(2016)
Systematic evaluation of pembrolizumab dosing in patients with advanced non-small-cell lung cancer.
Annals of Oncology
, 27
(7)
pp. 1291-1298.
10.1093/annonc/mdw174.
|
|
Childs, A;
Kirkwood, A;
Edeline, J;
Tu, VL;
Watkins, J;
Lamarca, A;
Alrifai, D;
... Meyer, T; + view all
(2016)
Ki-67 index and response to chemotherapy in patients with neuroendocrine tumours.
Endocrine-Related Cancer
, 23
(7)
pp. 563-570.
10.1530/ERC-16-0099.
|
|
|
Childs, A;
Vesely, C;
Ensell, L;
Lowe, H;
Luong, TV;
Caplin, ME;
Toumpanakis, C;
... Meyer, T; + view all
(2016)
Expression of somatostatin receptors 2 and 5 in circulating tumour cells from patients with neuroendocrine tumours.
British Journal of Cancer
, 115
(12)
pp. 1540-1547.
10.1038/bjc.2016.377.
|
|
|
Chung, R;
Maulik, A;
Hamarneh, A;
Hochhauser, D;
Hausenloy, DJ;
Walker, JM;
Yellon, DM;
(2016)
Effect of Remote Ischaemic Conditioning in ONCology patients undergoing chemotherapy: rationale and design of the ERIC-ONC study - a single-center, blinded, randomized controlled trial.
Clinical Cardiology
, 39
(2)
pp. 72-82.
10.1002/clc.22507.
|
|
|
Coulter, TI;
Chandra, A;
Bacon, CM;
Babar, J;
Curtis, J;
Screaton, N;
Goodlad, JR;
... Cant, AJ; + view all
(2016)
Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study.
J Allergy Clin Immunol
10.1016/j.jaci.2016.06.021.
|
|
|
Crockford, AJ;
(2016)
Deciphering tetraploid tolerance.
Doctoral thesis , UCL (University College London).
|
|
|
Crowley, C;
Klanrit, P;
Butler, CR;
Varanou, A;
Platé, M;
Hynds, RE;
Chambers, RC;
... Janes, SM; + view all
(2016)
Surface modification of a POSS-nanocomposite material to enhance cellular integration of a synthetic bioscaffold.
Biomaterials
, 83
pp. 283-293.
10.1016/j.biomaterials.2016.01.005.
|
|
D
|
Dillon, M;
Ellis, S;
Grove, L;
McLellan, L;
Clack, G;
Smith, S;
Laude, J;
... Harrington, K; + view all
(2016)
PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single agent and in combination with palliative radiation therapy in patients with solid tumours.
Presented at: ASCO 2016 Annual Meeting: Poster Session, Developmental Therapeutics - Clinical Pharmacology and Experimental Therapeutics, Chicago.
|
|
Dirix, L;
Swaisland, H;
Verheul, HMW;
Rottey, S;
Leunen, K;
Jerusalem, G;
Rolfo, C;
... Plummer, R; + view all
(2016)
Effect of Itraconazole and Rifampin on the Pharmacokinetics of Olaparib in Patients With Advanced Solid Tumors: Results of Two Phase I Open-label Studies.
Clinical Therapeutics
, 38
(10)
pp. 2286-2299.
10.1016/j.clinthera.2016.08.010.
|
|
Drummond, CJ;
Esfandiari, A;
Liu, J;
Lu, X;
Hutton, C;
Jackson, J;
Bennaceur, K;
... Lunec, J; + view all
(2016)
TP53 mutant MDM2-amplified cell lines selected for resistance to MDM2-p53 binding antagonists retain sensitivity to ionizing radiation.
Oncotarget
, 7
(29)
pp. 46203-46218.
10.18632/oncotarget.10073.
|
|
E
|
Edeline, J;
Blanc, JF;
Johnson, P;
Campillo-Gimenez, B;
Ross, P;
Ma, YT;
King, J;
... Meyer, T; + view all
(2016)
A multicentre comparison between Child Pugh and Albumin-Bilirubin scores in patients treated with sorafenib for Hepatocellular Carcinoma.
Liver International
, 36
(12)
pp. 1821-1828.
10.1111/liv.13170.
|
|
Eminowicz, GKD;
(2016)
Standardisation and optimisation of radical radiotherapy for cervical cancer.
Doctoral thesis , UCL (University College London).
|
|
Esfandiari, A;
Hawthorne, TA;
Nakjang, S;
Lunec, J;
(2016)
Chemical Inhibition of Wild-Type p53-Induced Phosphatase 1 (WIP1/PPM1D) by GSK2830371 Potentiates the Sensitivity to MDM2 Inhibitors in a p53-Dependent Manner.
Molecular Cancer Therapeutics
, 15
(3)
pp. 379-391.
10.1158/1535-7163.MCT-15-0651.
|
|
|
Evans, IC;
Barnes, JL;
Garner, IM;
Pearce, DR;
Maher, TM;
Shi-Wen, X;
Renzoni, EA;
... McAnulty, RJ; + view all
(2016)
Epigenetic Regulation of Cyclooxygenase-2 by methylation of c8orf4 in Pulmonary Fibrosis.
Clinical Science
, 130
(8)
pp. 575-586.
10.1042/CS20150697.
|
F
|
Flores-Borja, F;
Irshad, S;
Gordon, P;
Wong, F;
Sheriff, I;
Tutt, A;
Ng, T;
(2016)
Crosstalk between Innate Lymphoid Cells and Other Immune Cells in the Tumor Microenvironment.
Journal of Immunology Research
, Article 7803091. 10.1155/2016/7803091.
|
|
|
Flynn, MJ;
(2016)
Mechanistic and pharmacodynamic studies of ADCT-301, an Antibody Drug Conjugate targeting CD25-expressing haematological malignancies.
Doctoral thesis , UCL (University College London).
|
|
Flynn, MJ;
Zammarchi, F;
Tyrer, PC;
Akarca, AU;
Janghra, N;
Britten, CE;
Havenith, CEG;
... Hartley, JA; + view all
(2016)
ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer-Containing Antibody-Drug Conjugate (ADC) Targeting CD25-Expressing Hematological Malignancies.
Molecular Cancer Therapeutics
, 15
(11)
pp. 2709-2721.
10.1158/1535-7163.MCT-16-0233.
|
|
Forster, M;
Mendes, R;
Harrington, K;
Guerrero-Urbano, T;
Baines, H;
Spanswick, V;
Ensell, L;
... Beare, S; + view all
(2016)
A phase I study of olaparib in addition to cisplatin-based concurrent chemoradiotherapy for patients with high risk locally advanced squamous cell carcinoma of the head and neck (HNSCC).
Presented at: 2016 ASCO Annual Meeting, Chicago, IL, USA.
|
|
Foxall, E;
Pipili, A;
Jones, GE;
Wells, CM;
(2016)
Significance of kinase activity in the dynamic invadosome.
European Journal of Cell Biology
, 95
(11)
pp. 483-492.
10.1016/j.ejcb.2016.07.002.
|
|
G
|
Gillessen, S;
Omlin, A;
Attard, G;
de Bono, JS;
Efstathiou, E;
Fizazi, K;
Halabi, S;
... Tombal, B; + view all
(2016)
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015.
Annals of Oncology
, 26
pp. 1589-1604.
10.1093/annonc/mdw180.
|
|
|
Goh, G;
Schmid, R;
Guiver, K;
Arpornwirat, W;
Chitapanarux, I;
Ganju, V;
Im, SA;
... Swanton, C; + view all
(2016)
Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine.
PLOS Med
, 13
(12)
, Article e1002136. 10.1371/journal.pmed.1002136.
|
H
|
Hall, AR;
Burke, N;
Dongworth, RK;
Kalkhoran, SB;
Dyson, A;
Vicencio, JM;
Dorn Ii, GW;
... Hausenloy, DJ; + view all
(2016)
Hearts deficient in both Mfn1 and Mfn2 are protected against acute myocardial infarction.
Cell Death and Disease
, 7
, Article e2238. 10.1038/cddis.2016.139.
|
|
|
Harrington, K;
Forster, M;
Dillon, M;
Grove, L;
Adeleke, S;
Chen, S;
Diamond, J;
... Greenberg, J; + view all
(2016)
Patritumab or Placebo Plus Cetuximab and Platinum-Based Therapy in Squamous Cell Carcinoma of the Head and Neck (SCCHN): a Phase 2 Study.
Presented at: ASCO 2016 Annual Meeting: Poster Session, Head and Neck Cancer, Chicago.
|
|
Hiley, CT;
Le Quesne, J;
Santis, G;
Sharpe, R;
De Castro, DG;
Middleton, G;
Swanton, C;
(2016)
Challenges in molecular testing in non-small-cell lung cancer patients with advanced disease.
The Lancet
, 388
(10048)
pp. 1002-1011.
10.1016/S0140-6736(16)31340-X.
|
|
|
Hopper, C;
Jerjes, W;
Sultan, A;
Forster, M;
carnell, D;
Simeon, C;
Berg, K;
... Hamdoon, Z; + view all
(2016)
Disulfonated tetraphenyl chlorin (TPCS2a)–induced photochemical internalisation of bleomycin in patients with solid malignancies: A first-in-man phase I dose escalation clinical trial.
The Lancet Oncology
, 17
(9)
pp. 1217-1229.
10.1016/S1470-2045(16)30224-8.
|
|
Hughes, A;
Landers, D;
Arkenau, H-T;
Shah, S;
Stephens, R;
Mahal, A;
Simmons, M;
... Royle, J; + view all
(2016)
Development and Evaluation of a New Technological Way of Engaging Patients and Enhancing Understanding of Drug Tolerability in Early Clinical Development: PROACT.
Advances in Therapy
, 33
(6)
pp. 1012-1024.
10.1007/s12325-016-0335-4.
|
|
Hynds, RE;
(2016)
Characterisation of cultured airway basal cells to understand their role in human lung disease.
Doctoral thesis , UCL (University College London).
|
|
Hynds, RE;
Butler, CR;
Janes, SM;
Giangreco, A;
(2016)
Expansion of Human Airway Basal Stem Cells and Their Differentiation as 3D Tracheospheres.
Organoids: Methods in Molecular Biology
, 1576
pp. 43-53.
10.1007/7651_2016_5.
|
J
|
James, ND;
Spears, MR;
Clarke, NW;
Dearnaley, DP;
Mason, MD;
Parker, CC;
Ritchie, AW;
... STAMPEDE Investigators; + view all
(2016)
Failure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer: Data From Patients in the Control Arm of the STAMPEDE Trial.
JAMA Oncology
, 2
(3)
pp. 348-357.
10.1001/jamaoncol.2015.4350.
|
|
James, ND;
Sydes, MR;
Clarke, NW;
Mason, MD;
Dearnaley, DP;
Spears, MR;
Ritchie, AW;
... STAMPEDE investigators; + view all
(2016)
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.
Lancet
, 387
(10024)
pp. 1163-1177.
10.1016/S0140-6736(15)01037-5.
|
|
Johnston, EW;
Pye, H;
Bonet Carne, E;
Panagiotaki, E;
Patel, D;
Galazi, M;
Heavey, S;
... Punwani, S; + view all
(2016)
INNOVATE: A prospective cohort study combining serum and urinary biomarkers with novel diffusion-weighted magnetic resonance imaging for the prediction and characterization of prostate cancer.
BMC Cancer
, 16
(816)
10.1186/s12885-016-2856-2.
|
K
|
Kanu, N;
Cerone, MA;
Goh, G;
Zalmas, L-P;
Bartkova, J;
Dietzen, M;
McGranahan, N;
... Swanton, C; + view all
(2016)
DNA replication stress mediates APOBEC3 family mutagenesis in breast cancer.
Genome Biology
, 17
, Article 185. 10.1186/s13059-016-1042-9.
|
|
|
Kinna, A;
Tolner, B;
Rota, EM;
Titchener-Hooker, N;
Nesbeth, D;
Chester, K;
(2016)
IMAC capture of recombinant protein from unclarified mammalian cell feed streams.
Biotechnology and Bioengineering
, 113
(1)
pp. 130-140.
10.1002/bit.25705.
|
|
|
Konecny, G;
Kristeleit, RS;
(2016)
PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directions.
British Journal of Cancer
, 115
pp. 1157-1173.
10.1038/bjc.2016.311.
|
|
|
Kotwinski, PJ;
Smith, G;
Cooper, J;
Sanders, J;
Ma, L;
Teis, A;
Kotwinski, D;
... Breast cancer Early disease: Toxicity from Therapy with Epirubic; + view all
(2016)
Body Surface Area and Baseline Blood Pressure Predict Subclinical Anthracycline Cardiotoxicity in Women Treated for Early Breast Cancer.
PLOS One
, 11
(12)
, Article e0165262. 10.1371/journal.pone.0165262.
|
|
|
Kristeleit, RS;
Miller, RE;
Kohn, EC;
(2016)
Gynecologic Cancers: Emerging Novel Strategies for Targeting DNA Repair Deficiency.
American Society of Clinical Oncology Educational Book
, 2016
10.14694/EDBK_159086.
|
|
|
Kularatne, B;
Arora, R;
Elshstein, G;
Guppy, N;
Kirkwood, A;
Meyer, T;
Kristeleit, RS;
(2016)
Immunohistochemistry (IHC) evaluation of a novel 4-protein prognostic and predictive biomarker panel in endometrial cancer (EC).
In:
Abstract Book of the 41st ESMO Congress (ESMO 2016), 7-11 October 2016, Copenhagen, Denmar.
Oxford University Press (OUP): Policy A1
|
L
|
Lampada, A;
(2016)
Targeting autophagy in colorectal cancer.
Doctoral thesis , UCL (University College London).
|
|
Laskaratos, F-M;
Walker, M;
Naik, K;
Maragkoudakis, E;
Oikonomopoulos, N;
Grant, L;
Meyer, T;
... Toumpanakis, C; + view all
(2016)
Predictive factors of antiproliferative activity of octreotide LAR as first-line therapy for advanced neuroendocrine tumours.
British Journal of Cancer
, 115
(11)
pp. 1321-1327.
10.1038/bjc.2016.349.
|
|
Lawson, C;
Vicencio, JM;
Yellon, DM;
Davidson, SM;
(2016)
Microvesicles and exosomes: new players in metabolic and cardiovascular disease.
Journal of Endocrinology
, 228
(2)
R57-R71.
10.1530/JOE-15-0201.
|
|
Ledermann, JA;
Drew, Y;
Kristeleit, RS;
(2016)
Homologous recombination deficiency and ovarian cancer.
European Journal of Cancer
, 60
pp. 49-58.
10.1016/j.ejca.2016.03.005.
|
|
Lee, AJX;
Benamore, R;
Hofer, M;
Chitnis, M;
(2016)
Leptomeningeal carcinomatosis in non-small-cell lung cancer: initial response to erlotinib followed by relapse despite continuing radiological resolution of disease.
Oxford Medical Case Reports
, 2016
(9)
, Article omw069. 10.1093/omcr/omw069.
|
|
|
Lee, SM;
Falzon, M;
Blackhall, F;
Spicer, J;
Nicolson, M;
Chaudhuri, A;
Middleton, G;
... Hackshaw, A; + view all
(2016)
Randomized Prospective Biomarker Trial of ERCC1 for Comparing Platinum and Nonplatinum Therapy in Advanced Non-Small-Cell Lung Cancer: ERCC1 Trial (ET).
Journal of Clinical Oncology
, 35
(4)
pp. 402-411.
10.1200/JCO.2016.68.1841.
|
|
|
Lemech, CR;
Ensell, L;
Paterson, JC;
Eminowicz, G;
Lowe, H;
Arora, R;
Arkenau, H-T;
... Kristeleit, RS; + view all
(2016)
Enumeration and Molecular Characterisation of Circulating Tumour Cells in Endometrial Cancer.
Oncology
, 91
(1)
pp. 48-54.
10.1159/000445999.
|
|
Lopez-Guadamillas, E;
Fernandez-Marcos, PJ;
Pantoja, C;
Muñoz-Martin, M;
MartÃnez, D;
Gómez-López, G;
Campos-Olivas, R;
... Serrano, M; + view all
(2016)
p21(Cip1) plays a critical role in the physiological adaptation to fasting through activation of PPARα.
Sci Rep
, 6
, Article 34542. 10.1038/srep34542.
|
|
|
Lopez-Guadamillas, E;
Muñoz-Martin, M;
Martinez, S;
Pastor, J;
Fernandez-Marcos, PJ;
Serrano, M;
(2016)
PI3Kα inhibition reduces obesity in mice.
Aging
, 8
(11)
pp. 2747-2753.
10.18632/aging.101075.
|
|
|
Lorente, D;
Omlin, A;
Zafeiriou, Z;
Nava-Rodrigues, D;
Pérez-López, R;
Pezaro, C;
Mehra, N;
... de Bono, J; + view all
(2016)
Castration-Resistant Prostate Cancer Tissue Acquisition From Bone Metastases for Molecular Analyses.
Clinical Genitourinary Cancer
, 14
(6)
pp. 485-493.
10.1016/j.clgc.2016.04.016.
|
|
M
|
Mak, G;
Moschetta, M;
Arkenau, H-T;
(2016)
Reporting incidental germline variants in the context of day-to-day somatic genomic profiling.
Annals of Oncology
, 27
(5)
pp. 758-759.
10.1093/annonc/mdw078.
|
|
Mandair, D;
Vesely, C;
Ensell, L;
Lowe, H;
Spanswick, V;
Hartley, JA;
Caplin, ME;
(2016)
A comparison of CellCollector with CellSearch in patients with neuroendocrine tumours.
Endocrine-Related Cancer
, 23
(10)
L29-L32.
10.1530/ERC-16-0201.
|
|
Marina, NM;
Smeland, S;
Bielack, SS;
Bernstein, M;
Jovic, G;
Krailo, MD;
Hook, JM;
... Whelan, JS; + view all
(2016)
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial.
The Lancet Oncology
, 17
(10)
pp. 1396-1408.
10.1016/S1470-2045(16)30214-5.
|
|
|
Maughan, E;
Lesage, F;
Butler, CR;
Hynds, RE;
Hewitt, R;
Janes, SM;
Deprest, JA;
(2016)
Airway tissue engineering for congenital laryngotracheal disease.
Seminars in Pediatric Surgery
, 25
(3)
pp. 186-190.
10.1053/j.sempedsurg.2016.02.012.
|
|
Miller, RE;
Brown, NE;
Speirs, A;
Shaw, HM;
Adeleke, S;
Gougis, P;
Bennett, P;
... Kristeleit, RS; + view all
(2016)
The use of next generation sequencing (NGS) to guide patient selection for phase 1 clinical trials.
Annals of Oncology
, 27
(Suppl 6)
pp. 114-135.
10.1093/annonc/mdw368.44.
|
N
|
Nile, DL;
Rae, C;
Hyndman, IJ;
Gaze, MN;
Mairs, RJ;
(2016)
An evaluation in vitro of PARP-1 inhibitors, rucaparib and olaparib, as radiosensitisers for the treatment of neuroblastoma.
BMC Cancer
, 16
(1)
, Article 621. 10.1186/s12885-016-2656-8.
|
|
O
|
O'Connor, JP;
Aboagye, EO;
Adams, JE;
Aerts, HJ;
Barrington, SF;
Beer, AJ;
Boellaard, R;
... Waterton, JC; + view all
(2016)
Imaging biomarker roadmap for cancer studies.
Nat Rev Clin Oncol
10.1038/nrclinonc.2016.162.
(In press).
|
|
Okkenhaug, K;
Graupera, M;
Vanhaesebroeck, B;
(2016)
Targeting PI3K in Cancer: Impact on Tumor Cells, Their Protective Stroma, Angiogenesis, and Immunotherapy.
Cancer Discovery
, 6
(10)
pp. 1090-1105.
10.1158/2159-8290.CD-16-0716.
|
|
P
|
Perna, C;
Eminowicz, G;
Asghar, U;
Imseeh, G;
Kirkwood, A;
Mitra, A;
Arora, R;
... McCormack, M; + view all
(2016)
Uterine carcinosarcoma: a retrospective clinical cohort analysis.
Presented at: ESMO 2016: 41st ESMO Congress, Copenhagen, Denmark.
|
|
Plesner, T;
Arkenau, H-T;
Gimsing, P;
Krejcik, J;
Lemech, C;
Minnema, MC;
Lassen, U;
... Richardson, PG; + view all
(2016)
Phase 1/2 study of daratumumab, lenalidomide, and dexamethasone for relapsed multiple myeloma.
Blood
, 128
(14)
pp. 1821-1828.
10.1182/blood-2016-07-726729.
|
|
R
|
Richardson, SE;
(2016)
Modeling TEL-AML1 childhood acute lymphoblastic leukaemia using human pluripotent stem cells.
Doctoral thesis , UCL (University College London).
|
|
Riquelme, JA;
Westermeier, F;
Hall, AR;
Vicencio, JM;
Pedrozo, Z;
Ibacache, M;
Fuenzalida, B;
... Lavandero, S; + view all
(2016)
Dexmedetomidine protects the heart against ischemia-reperfusion injury by an endothelial eNOS/NO dependent mechanism.
Pharmacological Research
, 103
pp. 318-327.
10.1016/j.phrs.2015.11.004.
|
|
Rooshenas, L;
Elliott, D;
Wade, J;
Jepson, M;
Paramasivan, S;
Strong, S;
Wilson, C;
... POUT study group; + view all
(2016)
Conveying Equipoise during Recruitment for Clinical Trials: Qualitative Synthesis of Clinicians' Practices across Six Randomised Controlled Trials.
PLoS Med
, 13
(10)
, Article e1002147. 10.1371/journal.pmed.1002147.
|
|
|
Rosenthal, R;
McGranahan, N;
Herrero, J;
Taylor, BS;
Swanton, C;
(2016)
deconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution.
Genome Biol
, 17
(1)
p. 31.
10.1186/s13059-016-0893-4.
|
|
Rothermundt, C;
Seddon, BM;
Dileo, P;
Strauss, SJ;
Coleman, J;
Briggs, TW;
Haile, SR;
(2016)
Follow-up practices for high-grade extremity Osteosarcoma.
BMC Cancer
, 16
, Article 301. 10.1186/s12885-016-2333-y.
|
|
|
Rowley, MI;
Coolen, ACC;
Vojnovic, B;
Barber, PR;
(2016)
Correction: Robust Bayesian fluorescence lifetime estimation, decay model selection and instrument response determination for low-intensity FLIM imaging.
PLoS ONE
, 11
(8)
, Article e0162224. 10.1371/journal.pone.0162224.
|
|
|
Rowley, MI;
Coolen, ACC;
Vojnovic, B;
Barber, PR;
(2016)
Robust Bayesian Fluorescence Lifetime Estimation, Decay Model Selection and Instrument Response Determination for Low-Intensity FLIM Imaging.
PLoS One
, 11
(6)
, Article e0158404. 10.1371/journal.pone.0158404.
|
|
S
|
Salvi, S;
Casadio, V;
Conteduca, V;
Lolli, C;
Gurioli, G;
Martignano, F;
Schepisi, G;
... De Giorgi, U; + view all
(2016)
Circulating AR copy number and outcome to enzalutamide in docetaxel-treated metastatic castration-resistant prostate cancer.
Oncotarget
, 7
(25)
pp. 37839-37845.
10.18632/oncotarget.9341.
|
|
|
Savas, P;
Teo, ZL;
Lefevre, C;
Flensburg, C;
Caramia, F;
Alsop, K;
Mansour, M;
... Loi, S; + view all
(2016)
The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE".
PLoS Medicine
, 13
(12)
, Article e1002204. 10.1371/journal.pmed.1002204.
|
|
|
Scelo, G;
Hofmann, JN;
Banks, RE;
Bigot, P;
Bhatt, RS;
Cancel-Tassin, G;
Chew, SK;
... Chanock, SJ; + view all
(2016)
International cancer seminars: a focus on kidney cancer.
Annals of Oncology
, 27
(8)
pp. 1382-1385.
10.1093/annonc/mdw186.
|
|
|
Scheipl, S;
Barnard, M;
Cottone, L;
Jorgensen, M;
Drewry, DH;
Zuercher, WJ;
Turlais, F;
... Flanagan, AM; + view all
(2016)
EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen.
J Pathol
, 239
(3)
pp. 320-334.
10.1002/path.4729.
|
|
|
Seifert, W;
Posor, Y;
Schu, P;
Stenbeck, G;
Mundlos, S;
Klaassen, S;
Nuernberg, P;
... Kuehnisch, J; + view all
(2016)
The progressive ankylosis protein ANK facilitates clathrin- and adaptor-mediated membrane traffic at the trans-Golgi network-to-endosome interface.
Human Molecular Genetics
, 25
(17)
pp. 3836-3848.
10.1093/hmg/ddw230.
|
|
|
Sharma, RA;
Plummer, R;
Stock, JK;
Greenhalgh, TA;
Ataman, O;
Kelly, S;
Clay, R;
... Wedge, SR; + view all
(2016)
Clinical development of new drug-radiotherapy combinations.
NATURE REVIEWS CLINICAL ONCOLOGY
, 13
(10)
pp. 627-642.
10.1038/nrclinonc.2016.79.
|
|
|
Soria, JC;
Gan, HK;
Blagden, SP;
Plummer, R;
Arkenau, HT;
Ranson, M;
Evans, TRJ;
... Millward, M; + view all
(2016)
A phase I, pharmacokinetic and pharmacodynamic study of GSK2256098, a focal adhesion kinase inhibitor, in patients with advanced solid tumors.
Annals of Oncology
, 27
(12)
pp. 2268-2274.
10.1093/annonc/mdw427.
|
|
|
Soriano, EV;
Ivanova, ME;
Fletcher, G;
Riou, P;
Knowles, PP;
Barnouin, K;
Purkiss, A;
... McDonald, NQ; + view all
(2016)
aPKC Inhibition by Par3 CR3 Flanking Regions Controls Substrate Access and Underpins Apical-Junctional Polarization.
Developmental Cell
, 38
(4)
pp. 384-398.
10.1016/j.devcel.2016.07.018.
|
|
|
Stein, RC;
Dunn, JA;
Bartlett, JMS;
Campbell, AF;
Marshall, A;
Hall, P;
Rooshenas, L;
+ view all
(2016)
OPTIMA: a randomised feasibility study of personalised care in the treatment of women with early breast cancer.
(Health Technology Assessment
20(10)
, pp. pp. 1-202
).
National Institute of Health Research: UK.
|
|
|
Swanton, C;
Govindan, R;
(2016)
Clinical Implications of Genomic Discoveries in Lung Cancer.
New England Journal of Medicine
, 374
(19)
pp. 1864-1873.
10.1056/NEJMra1504688.
|
|
|
Szikriszt, B;
Poti, A;
Pipek, O;
Krzystanek, M;
Kanu, N;
Molnar, J;
Ribli, D;
... Szuts, D; + view all
(2016)
A comprehensive survey of the mutagenic impact of common cancer cytotoxics.
Genome Biology
, 17
, Article 99. 10.1186/s13059-016-0963-7.
|
|
T
|
Tape, CJ;
Ling, S;
Dimitriadi, M;
McMahon, KM;
Worboys, JD;
Leong, HS;
Norrie, IC;
... Jorgensen, C; + view all
(2016)
Oncogenic KRAS Regulates Tumor Cell Signaling via Stromal Reciprocation.
Cell
, 165
(4)
pp. 910-920.
10.1016/j.cell.2016.03.029.
|
|
|
Terrisse, AD;
Laurent, PA;
Garcia, C;
Gratacap, MP;
Vanhaesebroeck, B;
Sié, P;
Payrastre, B;
(2016)
The class I phosphoinositide 3-kinases α and β control antiphospholipid antibodies-induced platelet activation.
Thrombosis and Haemostasis
10.1160/TH15-08-0661.
|
|
Tosatto, A;
Sommaggio, R;
Kummerow, C;
Bentham, RB;
Blacker, TS;
Berecz, T;
Duchen, MR;
... Mammucari, C; + view all
(2016)
The mitochondrial calcium uniporter regulates breast cancer progression via HIF-1α.
EMBO Molecular Medicine
, 8
(5)
pp. 569-585.
10.15252/emmm.201606255.
|
|
V
|
Vanhaesebroeck, B;
Whitehead, MA;
Pineiro, R;
(2016)
Molecules in medicine mini-review: isoforms of PI3K in biology and disease.
Journal of Molecular Medicine
, 94
(1)
pp. 5-11.
10.1007/s00109-015-1352-5.
|
|
Vena, F;
(2016)
MEK inhibition in pancreas cancer.
Doctoral thesis , UCL (University College London).
|
|
W
|
Weitsman, G;
Barber, PR;
Nguyen, LK;
Lawler, K;
Patel, G;
Woodman, N;
Kelleher, MT;
... Ng, T; + view all
(2016)
HER2-HER3 dimer quantification by FLIM-FRET predicts breast cancer metastatic relapse independently of HER2 IHC status.
Oncotarget
, 7
(32)
pp. 51012-51026.
10.18632/oncotarget.9963.
|
|
Wulaningsih, W;
Holmberg, L;
Abeler-Doner, L;
Ng, T;
Rohrmann, S;
Van Hemelrijck, M;
(2016)
Associations of C-Reactive Protein, Granulocytes and Granulocyte-to-Lymphocyte Ratio with Mortality from Breast Cancer in Non-Institutionalized American Women.
PLoS ONE
, 11
(6)
, Article e0157482. 10.1371/journal.pone.0157482.
|
|
|
Wulaningsih, W;
Holmberg, L;
Garmo, H;
Karagiannis, SN;
Ahlstedt, S;
Malmstrom, H;
Lambe, M;
... Van Hemelrijck, M; + view all
(2016)
Investigating the association between allergen-specific immunoglobulin E, cancer risk and survival.
Oncoimmunology
, 5
(6)
, Article e1154250. 10.1080/2162402X.2016.1154250.
|
|
Z
|
Zamborszky, J;
Szikriszt, B;
Gervai, JZ;
Pipek, O;
Poti, A;
Krzystanek, M;
Ribli, D;
... Szuets, D; + view all
(2016)
Loss of BRCA1 or BRCA2 markedly increases the rate of base substitution mutagenesis and has distinct effects on genomic deletions.
Oncogene
, 36
(6)
pp. 746-755.
10.1038/onc.2016.243.
|
|
|
Zhang, R;
Fruhwirth, GO;
Coban, O;
Barrett, JE;
Burgoyne, T;
Lee, SH;
Simonson, PD;
... Selvin, PR; + view all
(2016)
Probing the Heterogeneity of Protein Kinase Activation in Cells by Super-Resolution Microscopy.
ACS Nano
, 11
(1)
pp. 249-257.
10.1021/acsnano.6b05356.
|
|
Zubairi, I;
Dean, E;
Molife, LR;
Lopez, J;
Ranson, M;
El-Khouly, F;
Savulsky, C;
... Evans, TRJ; + view all
(2016)
Phase 1 multicenter, open-label study to establish the maximum tolerated dose (MTD) of two administration schedules of E7389 (eribulin) liposomal formulation in patients (pts) with solid tumors.
Presented at: 2016 Jahrestagung der DGHO, OeGHO, SGMO und SGH, Leipzig, Germany.
|
